Analysts at Deutsche Bank lifted their price target on shares of Acadia Healthcare Co (NASDAQ:ACHC) from $33.00 to $44.00 in a research report issued to clients and investors on Thursday, Stock Ratings Network reports. The firm currently has a “hold” rating on the stock. Deutsche Bank’s price objective suggests a potential upside of 3.12% from the company’s current price.
Other equities research analysts have also recently issued reports about the stock. Analysts at BMO Capital Markets reiterated a “positive” rating on shares of Acadia Healthcare Co in a research note to investors on Thursday. Separately, analysts at Cantor Fitzgerald raised their price target on shares of Acadia Healthcare Co from $42.00 to $45.00 in a research note to investors on Wednesday. They now have a “buy” rating on the stock. Finally, analysts at Jefferies Group raised their price target on shares of Acadia Healthcare Co from $39.00 to $47.00 in a research note to investors on Wednesday. They now have a “buy” rating on the stock. Two research analysts have rated the stock with a hold rating and six have given a buy rating to the company’s stock. Acadia Healthcare Co currently has an average rating of “Buy” and an average target price of $39.60.
Acadia Healthcare Co (NASDAQ:ACHC) traded up 1.73% during mid-day trading on Thursday, hitting $43.41. The stock had a trading volume of 365,647 shares. Acadia Healthcare Co has a one year low of $18.64 and a one year high of $43.55. The stock’s 50-day moving average is $39.54 and its 200-day moving average is $35.93. The company has a market cap of $2.193 billion and a P/E ratio of 73.82.
Acadia Healthcare Co (NASDAQ:ACHC) last released its earnings data on Wednesday, October 30th. The company reported $0.29 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.27 by $0.02. The company had revenue of $184.70 million for the quarter, compared to the consensus estimate of $179.47 million. The company’s revenue for the quarter was up 79.1% on a year-over-year basis. Analysts expect that Acadia Healthcare Co will post $1.03 EPS for the current fiscal year.
In other Acadia Healthcare Co news, major shareholder Karen Marie Prince sold 20,000 shares of the company’s stock in a transaction dated Tuesday, October 29th. The stock was sold at an average price of $39.14, for a total value of $782,800.00. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. Major shareholders that own at least 10% of a company’s stock are required to disclose their transactions with the SEC.
Acadia Healthcare Company, Inc is a provider of inpatient behavioral healthcare services in the United States.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.